Digital Health Innovators: Senseonics’ Francine Kaufman In the most recent of the Health Innovators video series, pharmaphorum's founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics.
News Senseonics, TypeZero to develop artificial pancreas Deal will combine inControl algorithms with Eversense CGM.
News Senseonics' implantable glucose monitor passes test Company now looking to file for pre-marketing approval.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.